MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AR7

CAS No. : 80306-38-3

MCE 站：AR7

产品活性：AR7 是非典型的 RARA/RARα (视黄酸受体 α) 拮抗剂。AR7 特异性激活伴侣介导的自噬 (CMA) 活性，而不会影响自噬。

研究领域：Metabolic Enzyme/Protease

作用靶点：RAR/RXR

In Vitro: Treatment with RARA antagonist, AR7 (20 μM; for 16 h), increased lysosomal activity in WT and LRRK2^R1441G KI mutant MEFs.
AR7 (10, 20, 30 uM; 12, 24 hours) has no effect on macroautophagy in NIH 3T3 cells.
Chaperone-mediated autophagy (CMA) contributes to cellular quality control and the cellular response to stress through the selective degradation of cytosolic proteins in lysosomes. Decrease in CMA activity occurs in aging and in age-related disorders. Signaling through the retinoic acid receptor alpha (RARα) inhibits CMA. AR7 significantly activates CMA activity in mouse fibroblasts. A marked increase in CMA-activating potency is found when AR7 and GR1 are combined, supporting their cooperative effect. Treatment with the transcriptional repressor Actinomycin D partially reduces the stimulatory effect of AR7 on CMA, consistent with transcriptional changes contributing to the upregulation of CMA.

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Retinoic acid  |  Bexarotene  |  AM580  |  Talarozole  |  CD437  |  Fenretinide  |  Isotretinoin  |  AGN 193109  |  Magnolol  |  AGN 194310  |  Tamibarotene  |  Adapalene  |  TTNPB  |  UVI 3003  |  LG100268  |  Peretinoin  |  AGN 195183  |  Palovarotene  |  Tazarotene  |  Acitretin  |  BMS493  |  Tarenflurbil  |  CD3254  |  Ch55  |  LY2955303  |  PA452  |  9-cis-Retinoic acid  |  Oxybenzone  |  AC-55649  |  LG-100064

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。